Search Results - "Schapiro, R T"

Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis by Di Fabio, R P, Soderberg, J, Choi, T, Hansen, C R, Schapiro, R T

“…To determine the influence of an extended outpatient rehabilitation program on symptom frequency, fatigue, and functional status for persons with multiple…”
Get more information

Symptom management in multiple sclerosis by Schapiro, R T

“…Presently, the course of multiple sclerosis (MS) can be altered little, if at all. Appropriate symptom management, however, can change the course of lives and…”
Get more information

Symptomatic therapy of multiple sclerosis by Schapiro, R T, Langer, S L

“…Despite decades of aggressive research into the cause and cure of multiple sclerosis (MS), a direct management strategy remains lacking. As research continues,…”
Get more information

Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis by Nance, P W, Sheremata, W A, Lynch, S G, Vollmer, T, Hudson, S, Francis, G S, O'Connor, P, Cohen, J A, Schapiro, R T, Whitham, R, Mass, M K, Lindsey, J W, Shellenberger, K

“…Spasticity is a serious problem in multiple sclerosis (MS) and many patients do not achieve a satisfactory response to currently available oral antispasticity…”
Get more information

Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis by Schapiro, R T

“…Multiple sclerosis (MS) is a disease with tremendous variability and innumerable symptoms. Among the more common symptoms is spasticity. Despite a lack of full…”
Get full text

New advances in symptom management in multiple sclerosis by Schapiro, R T

“…Even with exciting new advances in the immunology of multiple sclerosis (MS), a definitive, etiologically aimed management strategy remains elusive. New…”
Get more information

Managing symptoms of multiple sclerosis by Schapiro, Randall T

Get more information

Medications used in the treatment of multiple sclerosis by Schapiro, R T

“…Recently, there have been numerous advances in the treatment of multiple sclerosis. This article focuses on reviewing the various forms of MS, managing its…”
Get more information

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial by Goodman, Andrew D, Prof, Brown, Theodore R, MD, Krupp, Lauren B, MD, Schapiro, Randall T, MD, Schwid, Steven R, MD, Cohen, Ron, MD, Marinucci, Lawrence N, MS, Blight, Andrew R, PhD

“…Summary Background Clinical studies suggested that fampridine (4-aminopyridine) improves motor function in people with multiple sclerosis. This phase III study…”
Get full text

Relative Risk of Pulmonary Transit Time to Longitudinal Strain, BNP and Other Established Risks of Heart Failure by Jane Cao, J., Weber, Jonathan, Bano, Ruqiyya, Passick, Michael, Cheng, Joshua, Schapiro, Wiliam, Grgas, Marie, Gliganic, Kathleen

Get full text

Estimated Left Ventricular End Diastolic Pressure by Left Atrial Transit Time Is a Long-term Risk of Heart Failure Hospitalization in a Prospective Cohort by Weber, Jonathan, Jane Cao, J., Bano, Ruqiyya, Passick, Michael, Ngai, Nora, Cheng, Joshua, Schapiro, Wiliam, Grgas, Marie, Gliganic, Kathleen, Dang, Olivia, Kapralos, Cristina, Musso, Elizabeth, Prieto, Natalie

Get full text

Primary CNS lymphoma presenting as multiple sclerosis. A case study by Bender, G P, Schapiro, R T

“…A case is described of a patient who presented with multifocal neurologic disease compatible with a diagnosis of multiple sclerosis. The predominance of…”
Get more information

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials by Goodman, Andrew D, Bethoux, Francois, Brown, Theodore R, Schapiro, Randall T, Cohen, Ron, Marinucci, Lawrence N, Henney, Herbert R, Blight, Andrew R, Agius, M, Arnason, BGW, Bethoux, FA, Bever, CT, Bowen, JD, Brown, TR, Dietrich, DW, Edwards, K, Freedman, MS, Freedman, M, Kachuck, NJ, Kaufman, MD, Keilson, M, Khan, O, Krupp, LB, Leist, TP, Lindsey, JW, Lublin, FD, Mass, MK, Mattson, D, McGowan, D, Naismith, R, O’Connell, C, Oger, JJ, Panitch, H, Picone, MA, Rammohan, KW, Schapiro, RT, Schwid, SR, Scott, T, Short, C, Thrower, BW, Vollmer, TL, Camac, A, Cooper, JA, Chumley, WF, Cross, A, Dunnigan, RT, Gitt, JS, Hillen, M, Jeffrey, DR, Khatri, BO, Kresa-Reahl, K, Moon, S, Preiningerova, J, Tullman, M, Weinstock-Guttman, B, Wynn, DR

“…Background: In Phase 3 double-blind trials (MS-F203 and MS-F204), dalfampridine extended release tablets 10 mg twice daily (dalfampridine-ER; prolonged-release…”
Get full text

Sustained-release fampridine consistently improves walking speed and leg strength in multiple sclerosis: a phase 3 trial by Goodman, AD, Schwid, SR, Brown, T R, Krupp, L B, Schapiro, R T, Marinucci, L N, Cohen, R, Blight, A R

“…Background: A prior Phase 3 study of sustained-release fampridine (4-aminopyridine) in MS showed beneficial effects on ambulation and leg strength. Objective:…”
Get full text

The current management of multiple sclerosis by Schapiro, R T, van den Noort, S, Scheinberg, L

Get more information

Normal Values of Right Ventricular Size and Function by Real-time 3-Dimensional Echocardiography: Comparison with Cardiac Magnetic Resonance Imaging by Gopal, Aasha S., MD, FACC, Chukwu, Ebere O., MD, Iwuchukwu, Chizor J., MD, Katz, Alan S., MD, Toole, Rena S., RDCS, Schapiro, William, RT, Reichek, Nathaniel, MD

“…Background Assessment of right ventricular function by 2-dimensional echocardiography (2DECHO) is difficult because of its complex shape. Real-time…”
Get full text

Pharmacologic Options for the Management of Multiple Sclerosis Symptoms by Schapiro, Randall T.

“…Multiple sclerosis (MS) is a disease with a wide-ranging impact on physical functioning. Although pharmacotherapy plays an indispensable role in the management…”
Get full text

Left Ventricular Structure and Function for Postmyocardial Infarction and Heart Failure Risk Stratification by Three-dimensional Echocardiography by Gopal, Aasha S., MD, Chukwu, Ebere O., MD, Mihalatos, Dennis G., MD, Katz, Alan S., MD, Mathew, Sunil T., MD, Lachmann, Justine S., MD, Toole, Rena S., RDCS, Schapiro, William, RT, Reichek, Nathaniel, MD

Get full text

Field testing of a minimal record of disability in multiple sclerosis: the United States and Canada by LaRocca, N G, Scheinberg, L C, Slater, R J, Giesser, B, Smith, C R, Traugott, U, Schapiro, R T, Paty, D W, Franklin, G M, Cobble, N

“…The IFMSS Minimal Record of Disability (MRD) in Multiple Sclerosis was field tested at eight medical centers in the U.S. and Canada. The goals were to conduct…”
Get more information